本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Guided Therapeutics, Inc.

0.2740
0.0000
成交量:601.00
成交额:164.35
市值:2,290.62万
市盈率:-0.95
高:0.2740
开:0.2740
低:0.2740
收:0.2740
52周最高:0.3220
52周最低:0.0644
股本:8,359.92万
流通股本:2,793.01万
量比:0.02
换手率:0.00%
股息:- -
股息率:- -
每股收益(TTM):-0.2881
每股收益(LYR):-0.0372
净资产收益率:43.94%
总资产收益率:-129.56%
市净率:-2.99
市盈率(LYR):-7.36

数据加载中...

2025/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/16

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/03/31

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/12/21

重要事件披露

Form 8-K - Current report
2024/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/27

重要事件披露

Form 8-K - Current report
2024/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/20

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/16

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/30

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/09

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/23

SEC问询函

CORRESP [Cover] - Correspondence
2023/01/13

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2022/11/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]